MedPath

Comparision of three different doses of nalbuphine which is added to to Intrathecal hyperbaric bupivacaine in patients undergoing knee joint surgeries.

Phase 2
Conditions
Health Condition 1: M239- Unspecified internal derangement of knee
Registration Number
CTRI/2019/08/020916
Lead Sponsor
Kalinga institute of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

American society of anesthesiologists (ASA) Physical status I and II,patient posted for surgery of knee joint.

Exclusion Criteria

ASA PH III and IV,Height <150cm,BMI >30,Contraindication to spinal anesthesia,H/o adverse reactions to opioids,pregnancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath